Wall Street analyst estimates for iSpecimen Inc. (ISPC): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
iSpecimen Inc. operates a sophisticated technological platform that effectively bridges the gap between life science researchers and crucial human biological materials. Its proprietary cloud-based system empowers scientists to efficiently locate and access a vast array of biospecimens—such as biofluids, tissues, and living cells—as well as connect with potential study subjects, all sourced from a global network of healthcare providers, including hospitals, laboratories, bioba...
Analyst Consensus
| Strong Buy | 0 |
| Buy | 2 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 2 |
| Avg rating (1-5) | 1.00 |
Valuation Ratios
| Price / Book | 1.10 |
| EV / EBITDA | 0.39 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.4M | $4.3M | $8.2M | $11.1M | $10.4M | $9.9M | $9.3M | $1.9M |
| Cost of Revenue | $2.4M | $2.1M | $3.6M | $5.2M | $4.8M | $4.8M | $5.3M | $1.9M |
| Gross Profit | $2.0M | $2.2M | $4.6M | $5.9M | $5.6M | $5.1M | $4.0M | $24110 |
| Research & Development | $1.2M | $993329 | $1.5M | $1.8M | $2.7M | $3.6M | $3.5M | $2.2M |
| Selling, General & Admin | $3.5M | $4.3M | $5.0M | $9.4M | $12.4M | $11.7M | $12.6M | $6.6M |
| Operating Expenses | $5.4M | $6.1M | $7.0M | $11.8M | $15.8M | $16.3M | $16.7M | $9.0M |
| Operating Income | -$3.4M | -$3.9M | -$2.4M | -$5.9M | -$10.2M | -$11.2M | -$12.7M | -$9.0M |
| EBITDA | -$3.8M | -$2.5M | -$1.7M | -$5.9M | -$8.8M | -$8.8M | -$10.4M | -$8.7M |
| Interest Expense | $1.2M | $1.7M | $2.1M | $2.1M | $238963 | $230785 | $220074 | $1949 |
| Pre-tax Income | -$5.5M | -$4.9M | -$4.7M | -$9.0M | -$10.2M | -$11.1M | -$12.5M | -$10.5M |
| Income Tax | -$127000 | -$157000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | -$5.3M | -$4.7M | -$4.7M | -$9.0M | -$10.2M | -$11.1M | -$12.5M | -$10.5M |
| EPS | $-651.51 | $-575.97 | $-566.83 | $-820.91 | $-926.78 | $-982.11 | $-703.26 | $-91.15 |
| EPS (Diluted) | $-651.51 | $-575.97 | $-566.83 | $-820.91 | $-926.78 | $-982.11 | $-703.26 | $-91.15 |
| Shares Outstanding (Diluted) | $8207 | $8207 | $8207 | $10916 | $11055 | $11301 | $17771 | $115061 |
Price
| Price | $1.37 |
| Market Cap | $0M |
| Exchange | NASDAQ |
| Country | US |
Related companies: BIAF · BIVI · BJDX · GLMD · HSCS · NDRA · SHPH
Explore sector: Healthcare · Medical - Diagnostics & Research
More sections of ISPC: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks